INMED PHARMACEUTICALS INC. Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four
INMED PHARMACEUTICALS INC. (INM) had Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four of $200.66 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Leases › Lessee, Operating Lease, Liability, to be Paid, Rolling Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour · last filed 2022-11-14
- 2022-09-30: Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four $200.66K.
| Period end | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four |
|---|---|
| 2022-09-30 | $200.66K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |